In this sense, our results show that the migratory capacity of MIO-M1 cells induced by α2M* depends on the intracellular distribution and traffic of LRP1 to the PM, which may have special clinical connotations in the treatment of proliferative retinopathies. This evidence concerns the gene LRP1 and retinal disorder.